2018
DOI: 10.1080/10717544.2018.1461955
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease

Abstract: Alzheimer’s disease is a neurodegenerative disorder mainly characterized by β-amyloid deposit and tau hyperphosphorylation with no curative treatments. Curcumin (Cur) has been proved to have potential use in Alzheimer’s disease with its anti-amyloid, anti-inflammatory, and anti-oxidant properties, etc. However, its hydrophobicity and low bioavailability hinder its application. In this paper, we designed a novel brain-target nanoparticle, poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG) conjuga… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
108
1
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 178 publications
(112 citation statements)
references
References 62 publications
2
108
1
1
Order By: Relevance
“…Overall, this study offered PLGA nanoparticles as a promising tool for the delivery of drugs in treatment of AD. 45 Fan et al 48 also prepared curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide (PLGA-PEG-B6/Cur). The in vitro assays including dynamic light scattering (DLS), flow cytometry (FCM), red blood cell (RBC) lysis, and thromboelastographic (TEG) analysis showed good bio-safety and high bioavailability of PLGA-PEG-B6/Cur.…”
Section: Application Of Nano-curcumin In Admentioning
confidence: 99%
See 1 more Smart Citation
“…Overall, this study offered PLGA nanoparticles as a promising tool for the delivery of drugs in treatment of AD. 45 Fan et al 48 also prepared curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide (PLGA-PEG-B6/Cur). The in vitro assays including dynamic light scattering (DLS), flow cytometry (FCM), red blood cell (RBC) lysis, and thromboelastographic (TEG) analysis showed good bio-safety and high bioavailability of PLGA-PEG-B6/Cur.…”
Section: Application Of Nano-curcumin In Admentioning
confidence: 99%
“…In conclusion, the results of the current study illustrated that PLGA-PEG-B6/Cur might be considered as a promising therapeutic strategy for the treatment of AD in the future. 48…”
Section: Application Of Nano-curcumin In Admentioning
confidence: 99%
“…This demonstrated that the green fluorescence emitted by free curcumin inside the cells was very weak, which indicated that most of the free curcumin was not taken up by the macrophage cell line, RAW 264.7. As NPs might have promising potential for highly efficient intracellular drug delivery [ 41 , 42 ], it was observed that curcumin-loaded CS-BSA NPs showed increased fluorescence intensity when compared with cells treated with free curcumin, suggesting that CS-BSA NPs could improve the cellular uptake of curcumin. Herein, this observation indicated that CS-BSA NPs could effectively promote drug accumulation within the cells.…”
Section: Resultsmentioning
confidence: 99%
“…A part of the fixed brain as well as the distal ileum and proximal colon tissues were embedded in paraffin, cut into 5 μm sections, stained with hematoxylin and eosin (HE), and examined by light microscopy (n = 6/group). The Aβ load in the brains was assessed using Bielschowsky silver stain (BSS), which was performed according to the previously published protocols [27]. A portion of intestinal (distal ileum specimens and proximal colon) tissue was processed for ultrastructural examination.…”
Section: Histopathological Examinationmentioning
confidence: 99%
“…As one of the major side chains and enzymatic origin oxysterols found in the human circulation, 27-hydroxycholesterol (27-OHC) is ubiquitously produced by the mitochondrial enzyme CYP27A1 [13]. 27-OHC has been suggested to be involved in the pathogenesis of gastrointestinal and neurodegenerative diseases [14] due to its strong pro-inflammatory properties and ability to act as an endogenous selective estrogen receptor modulator (SERM). It is able to act as ligands for different isoforms of the estrogen receptor (ER) [15].…”
Section: Introductionmentioning
confidence: 99%